Search
Close this search box.
×
Search
[custom_company_search_form]
Lithium
45.28
0.49%
Gold
2,667.30
0.52%
Copper
4.13
(0.53%)
Oil
70.27
1.78%
Bitcoin
97,794.65
3.65%
FTSE 100
8,119.02
0.42%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.31%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.30
0.52%
Copper
4.13
(0.53%)
Oil
70.27
1.78%
Bitcoin
97,794.65
3.65%
FTSE 100
8,119.02
0.42%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.31%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.30
0.52%
Copper
4.13
(0.53%)
Oil
70.27
1.78%
Bitcoin
97,794.65
3.65%
FTSE 100
8,119.02
0.42%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.31%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.30
0.52%
Copper
4.13
(0.53%)
Oil
70.27
1.78%
Bitcoin
97,794.65
3.65%
FTSE 100
8,119.02
0.42%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.31%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.30
0.52%
Copper
4.13
(0.53%)
Oil
70.27
1.78%
Bitcoin
97,794.65
3.65%
FTSE 100
8,119.02
0.42%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.31%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.30
0.52%
Copper
4.13
(0.53%)
Oil
70.27
1.78%
Bitcoin
97,794.65
3.65%
FTSE 100
8,119.02
0.42%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.31%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.30
0.52%
Copper
4.13
(0.53%)
Oil
70.27
1.78%
Bitcoin
97,794.65
3.65%
FTSE 100
8,119.02
0.42%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.31%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.30
0.52%
Copper
4.13
(0.53%)
Oil
70.27
1.78%
Bitcoin
97,794.65
3.65%
FTSE 100
8,119.02
0.42%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.31%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.30
0.52%
Copper
4.13
(0.53%)
Oil
70.27
1.78%
Bitcoin
97,794.65
3.65%
FTSE 100
8,119.02
0.42%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.31%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.30
0.52%
Copper
4.13
(0.53%)
Oil
70.27
1.78%
Bitcoin
97,794.65
3.65%
FTSE 100
8,119.02
0.42%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.31%
Hang Seng
19,601.11
(0.23%)

Stock Piper AI Index

Stock Piper AI Index

Subscribe
Lithium
45.28
0.49%
Gold
2,667.30
0.52%
Copper
4.13
(0.53%)
Oil
70.27
1.78%
Bitcoin
97,794.65
3.65%
FTSE 100
8,119.02
0.42%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.31%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.30
0.52%
Copper
4.13
(0.53%)
Oil
70.27
1.78%
Bitcoin
97,794.65
3.65%
FTSE 100
8,119.02
0.42%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.31%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.30
0.52%
Copper
4.13
(0.53%)
Oil
70.27
1.78%
Bitcoin
97,794.65
3.65%
FTSE 100
8,119.02
0.42%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.31%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.30
0.52%
Copper
4.13
(0.53%)
Oil
70.27
1.78%
Bitcoin
97,794.65
3.65%
FTSE 100
8,119.02
0.42%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.31%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.30
0.52%
Copper
4.13
(0.53%)
Oil
70.27
1.78%
Bitcoin
97,794.65
3.65%
FTSE 100
8,119.02
0.42%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.31%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.30
0.52%
Copper
4.13
(0.53%)
Oil
70.27
1.78%
Bitcoin
97,794.65
3.65%
FTSE 100
8,119.02
0.42%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.31%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.30
0.52%
Copper
4.13
(0.53%)
Oil
70.27
1.78%
Bitcoin
97,794.65
3.65%
FTSE 100
8,119.02
0.42%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.31%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.30
0.52%
Copper
4.13
(0.53%)
Oil
70.27
1.78%
Bitcoin
97,794.65
3.65%
FTSE 100
8,119.02
0.42%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.31%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.30
0.52%
Copper
4.13
(0.53%)
Oil
70.27
1.78%
Bitcoin
97,794.65
3.65%
FTSE 100
8,119.02
0.42%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.31%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.30
0.52%
Copper
4.13
(0.53%)
Oil
70.27
1.78%
Bitcoin
97,794.65
3.65%
FTSE 100
8,119.02
0.42%
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.15
1.11%
USD/AUD
0.65
0.31%
Hang Seng
19,601.11
(0.23%)

Imugene Ltd

IMU

ASX

Imugene Limited (IMU) is a clinical stage immuno-oncology company developing arrange of new and novel immunotherapies that to activate the immune system of cancer patients to treat and eradicate tumours. Our unique platform technologies seek to harness the body's immune system against tumours, potentially achieving a similar or greater effect than synthetically manufactured monoclonal antibody and other immunotherapies.

Latest Posts

Line Chart with Gradient
Price
$0.037
-0.003 (-7.5%)
At Close 20/11 (AEST)
Related Companies
ZELIRA THERAPEUTICS LIMITED
$ZLD
BPH GLOBAL LTD
$BP8DD
ANTEOTECH LTD
$ADO
TELIX PHARMACEUTICALS LIMITED
$TLX
PROBIOTEC LIMITED
$PBP

Leave a Comment on IMU


Comments for IMU

    Latest Posts

    imugene-asx-imu-celebrates-breakthrough-in-cancer-trial-imu
    Health Care $IMU
    Imugene (ASX: $IMU) celebrates breakthrough in cancer trialPatient with bile tract cancer shows complete response for over two years using VAXINIA
    November 5, 2024
    imugene-asx-imu-doses-first-patient-in-bile-tract-cancer-trial-imu
    Health Care $IMU

    Imugene (ASX: $IMU) doses first patient in bile tract cancer trial

    Phase 1 trial progresses with positive responses in gastrointestinal cancers

    July 10, 2024
    imugene-asx-imu-presents-promising-cancer-immunotherapy-data-at-aacr-annual-meeting-imu
    Health Care $IMU

    Imugene (ASX: $IMU) presents promising cancer immunotherapy data at AACR annual meeting

    AACR Annual Meeting 2024 showcases Imugene's VAXINIA and HER-Vaxx advancements

    April 8, 2024
    imugene-asx-imu-receives-cf33-patent-grant-in-china-imu
    Health Care $IMU

    Imugene (ASX: $IMU) receives CF33 patent grant in China

    CF33 VAXINIA patent granted in China, protecting oncolytic virotherapy

    April 4, 2024
    imugene-asx-imu-presents-vaxinia-for-cholangiocarcinoma-at-2024-conference-imu
    Health Care $IMU

    Imugene (ASX: $IMU) presents VAXINIA for cholangiocarcinoma at 2024 conference

    CF33-hNIS technology selected for oral and poster presentations at Cholangiocarcinoma Foundation Annual Conference

    April 3, 2024
    imugene-asx-imu-secures-european-patent-for-pd1-vaxx-cancer-vaccine-imu
    Health Care $IMU

    Imugene (ASX: $IMU) secures european patent for pd1-vaxx cancer vaccine

    European Patent Office issues notification of intention to grant patent for PD1-Vaxx cancer vaccine

    January 14, 2024
    imugene-asximu-secures-european-patent-for-pd1-vaxx-cancer-vaccine-imu
    Health Care $IMU

    Imugene (ASX:$IMU) secures european patent for pd1-vaxx cancer vaccine

    European Patent Office issues notification of intention to grant patent for PD1-Vaxx cancer vaccine

    December 10, 2023
    imugene-asximu-secures-fda-fast-track-designation-for-bile-duct-cancer-imu
    Health Care $IMU

    Imugene (ASX:IMU) secures FDA fast track designation for bile duct cancer

    Fast track designation to expedite MAST clinical program for CF33-hNIS (VAXINIA)

    November 30, 2023

    IMU

    $IMU

    Imugene (ASX: $IMU) celebrates breakthrough in cancer trial

    Patient with bile tract cancer shows complete response for over two years using VAXINIA

    IMU

    $IMU

    Imugene (ASX: $IMU) doses first patient in bile tract cancer trial

    Phase 1 trial progresses with positive responses in gastrointestinal cancers

    IMU

    $IMU

    Imugene (ASX: $IMU) presents promising cancer immunotherapy data at AACR annual meeting

    AACR Annual Meeting 2024 showcases Imugene's VAXINIA and HER-Vaxx advancements

    IMU

    $IMU

    Imugene (ASX: $IMU) receives CF33 patent grant in China

    CF33 VAXINIA patent granted in China, protecting oncolytic virotherapy

    IMU

    $IMU

    Imugene (ASX: $IMU) presents VAXINIA for cholangiocarcinoma at 2024 conference

    CF33-hNIS technology selected for oral and poster presentations at Cholangiocarcinoma Foundation Annual Conference

    IMU

    $IMU

    Imugene (ASX: $IMU) secures european patent for pd1-vaxx cancer vaccine

    European Patent Office issues notification of intention to grant patent for PD1-Vaxx cancer vaccine

    IMU

    $IMU

    Imugene (ASX:$IMU) secures european patent for pd1-vaxx cancer vaccine

    European Patent Office issues notification of intention to grant patent for PD1-Vaxx cancer vaccine

    IMU

    $IMU

    Imugene (ASX:IMU) secures FDA fast track designation for bile duct cancer

    Fast track designation to expedite MAST clinical program for CF33-hNIS (VAXINIA)

    Related Companies
    INVION LIMITED
    $IVX
    CAMBIUM BIO LIMITED
    $CMB
    PYC THERAPEUTICS LIMITED
    $PYC
    TELIX PHARMACEUTICALS LIMITED
    $TLX
    ECOFIBRE LIMITED
    $EOF

    ASX News, First
    & Fast.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    By clicking Subscribe, you agree to our Terms & Conditions
    © 2024 Stock Piper.
    All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support

    Socials

    Facebook
    Twitter
    LinkedIn
    © 2024 Stock Piper. All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support
    © 2024 Stock Piper. All rights reserved
    Social Media Auto Publish Powered By : XYZScripts.com
    Stock Piper AI Index
    Subscribe
    Join FREE Newsletter

    Stock Piper AI Index Coming Soon!

    Join our Newsletter to gain exclusive insight and be notified once we are live.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    Get all the latest market updates straight to your inbox.

    By clicking Subscribe, you agree to our Terms & Conditions